ENTPD1 and colorectal carcinoma: It was discovered that about 64% of all Treg cells in the blood of CRC patientswere CD39+, which was at significant variance with the Treg cell frequency inthe blood of healthy donors (p = 0.0008), where CD39+ cellsonly accounted for 42% of all Treg cells.